Histotripsy for Liver Cancer: Dr. Jennifer Linehan explains this new treatment at Saint John's

4 Views
Published
Dr. Jennifer Linehan, Urologic Oncologist and Director of Urology Translational Research at Providence, Saint John's Cancer Institute reveals the promise of histotripsy beyond the treatment of liver cancer. Histotripsy, by HistoSonics, Inc., is a revolutionary technology that can destroy tumors without surgery or endocsopy-related techniques. Using focused ultrasound, cancer cells are disrupted from outside the body, which may allow more patients with surgical or medical complications to benefit from this truly non-invasive procedure. Histotripsy forms a bubble cloud of energy within the targeted area which systemically traces the inside of the tumor until it is destroyed, leaving the sourrounding healthy tissue completely in tact.

Learn more:
https://www.saintjohnscancer.org/gastrointestinal/conditions-we-treat/liver-cancer/histotripsy-for-liver-cancer/

#histotripsy #livercancer
Category
Urology
Be the first to comment